|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,247.90 INR | -1.20% |
|
-7.63% | -7.26% |
| 24/12 | Concord Biotech Limited Announces Resignation of Hina Patel as Company Secretary and Compliance Officer, Effective January 21, 2026 | CI |
| 18/12 | Concord Biotech Names CFO | MT |
Chart calendar Concord Biotech Limited
Upcoming events on Concord Biotech Limited
| 05/02/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 21/05/2026 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 07/08/2026 | Q1 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 18/11/2026 | Q2 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Concord Biotech Limited
| 14/11/2025 | Q2 2026 Earnings Call |
| 13/11/2025 | Q2 2026 Earnings Release |
| 19/09/2025 | Investor Meeting - Kotak Securities |
| 19/09/2025 | Investor Meeting - Kotak Securities |
| 17/09/2025 | Investor Meeting - Jefferies India |
| 09/09/2025 | Annual General Meeting |
| 11/08/2025 | Q1 2026 Earnings Call |
| 08/08/2025 | Q1 2026 Earnings Release |
| 10/06/2025 | Non-Deal Roadshow - Day 2 |
| 09/06/2025 | Investor Meeting |
| 09/06/2025 | Non-Deal Roadshow - Day 1 |
| 30/05/2025 | Q4 2025 Earnings Call |
| 29/05/2025 | Q4 2025 Earnings Release |
| 21/03/2025 | Investor Meeting |
| 13/03/2025 | Investor Meeting - Macquarie India |
| 06/03/2025 | Investor Meeting - Centrum Broking |
| 27/02/2025 | Investor Meeting - BofA Securities |
| 14/02/2025 | Q3 2025 Earnings Call |
| 13/02/2025 | Q3 2025 Earnings Release |
| 22/11/2024 | Kotak Midcap Conference |
Past dividends on Concord Biotech Limited
| 03/09/2025 | Annual 10.7 INR |
| 21/06/2024 | Annual 8.75 INR |
Annual results
| Fiscal Period | March | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 0,00 | 10 169 9 917 2.54% | 12 001 11 691 2.65% | 12 632 | 15 656 | 18 523 |
|
EBITDA Million INR | Released Forecast Spread | 0,00 | 4 316 4 228 2.08% | 5 063 4 805 5.37% | 4 905 | 6 240 | 7 520 |
|
EBIT Million INR | Released Forecast Spread | 0,00 | 3 780 3 647 3.63% | 4 520 4 145 9.04% | 4 331 | 5 715 | 7 094 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 0,00 | 4 126 3 974 3.82% | 4 959 4 708 5.33% | 4 936 | 6 339 | 7 947 |
|
Net income Million INR | Released Forecast Spread | 2 401 | 3 081 3 009 2.39% | 3 716 3 537 5.07% | 3 617 | 4 570 | 5 715 |
|
EPS INR | Released Forecast Spread | 23,0 | 29,5 28,9 2.08% | 35,5 33,9 4.8% | 33,7 | 42,5 | 53,4 |
| Announcement Date | 01/07/23 | 24/05/24 | 29/05/25 | - |
Quarterly results
| Fiscal Period | March | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 2 623 2 297 14.24% | 2 408 2 660 -9.49% | 3 190 3 144 1.45% | 2 158 2 231 -3.25% | 3 102 2 865 8.28% | 2 442 2 895 -15.64% | 4 299 3 743 14.85% | 2 040 2 368 -13.84% | 2 933 | 2 827 |
|
EBITDA Million INR | Released Forecast Spread | 1 192 940 26.86% | 1 059 1 149 -7.78% | 1 343 1 329 1.04% | 813 829 -1.9% | 1 367 1 222 11.85% | 980 1 238 -20.85% | 1 904 1 544 23.33% | 614 890 -31.01% | 988 | 1 068 |
|
EBIT Million INR | Released Forecast Spread | 1 059 630 68.08% | 924 999 -7.52% | 1 206 1 203 0.22% | 681 726 -6.2% | 1 234 920 34.09% | 847 1 163 -27.18% | 1 758 1 314 33.79% | 436 740 -41.05% | 544 | 925 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 1 132 696 62.61% | 1 001 1 076 -6.99% | 1 287 1 261 2.08% | 782 785 -0.42% | 1 333 1 035 28.79% | 993 1 269 -21.73% | 1 851 1 432 29.26% | 572 888 -35.54% | 657 | 1 074 |
|
Net income Million INR | Released Forecast Spread | 810 681 19.06% | 776 807 -3.84% | 950 955 -0.45% | 596 641 -6.96% | 957 895 7.01% | 759 919 -17.34% | 1 404 1 143 22.88% | 441 652 -32.37% | 697 | 773 |
|
EPS INR | Released Forecast Spread | 7,74 5,40 43.33% | 7,41 7,80 -5% | 9,08 9,10 -0.22% | 5,70 6,50 -12.31% | 9,15 7,40 23.65% | 7,26 8,90 -18.43% | 13,4 10,2 31.57% | 4,21 6,30 -33.17% | 4,80 | 7,10 |
| Announcement Date | 08/11/23 | 08/02/24 | 24/05/24 | 09/08/24 | 11/11/24 | 13/02/25 | 29/05/25 | 08/08/25 | - | - |
| 30/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 02/02/2026 | Q1 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 03/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 05/02/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 05/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 05/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 06/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 11/02/2026 | Q2 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 12/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 13/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
Past sector events for Concord Biotech Limited
| 21/01/2026 | Q4 2025 Earnings Release | |
| 19/01/2026 | Q2 2026 Sales and Revenue Release - Trading Update | |
| 09/01/2026 | December 2025 Sales and Revenue Release | |
| 11/12/2025 | Q4 2025 Earnings Release | |
| 08/12/2025 | November 2025 Sales and Revenue Release | |
| 14/11/2025 | Q4 2025 Earnings Release | |
| 14/11/2025 | Q3 2025 Earnings Release | |
| 14/11/2025 | Q3 2025 Earnings Release | |
| 14/11/2025 | Q3 2025 Earnings Release | |
| 14/11/2025 | Q3 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CONCORDBIO Stock
- Calendar Concord Biotech Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















